Glucagon-like peptide-1 receptor agonists in neoplastic diseases
Glucagon-like peptide-1 receptor agonist (GLP-1RA), a novel hypoglycemic agent for the treatment of type 2 diabetes, has well-known effects such as lowering blood sugar, ameliorating inflammation, reducing weight, and lowering blood lipids. It has also been shown that it can influence the proliferat...
Gespeichert in:
| Hauptverfasser: | , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Frontiers Media S.A.
2024-09-01
|
| Schriftenreihe: | Frontiers in Endocrinology |
| Schlagworte: | |
| Online-Zugang: | https://www.frontiersin.org/articles/10.3389/fendo.2024.1465881/full |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|
